| Genetic risk and a primary role for cell-mediated immune mechanisms in multiple sclerosis Nature 476 (7359), 214-219, 2011 | 2779 | 2011 |
| Analysis of immune-related loci identifies 48 new susceptibility variants for multiple sclerosis International IBD Genetics Consortium (IIBDGC), C Agliardi, L Alfredsson, ... Nature genetics 45 (11), 1353-1360, 2013 | 1221 | 2013 |
| The influence of the proinflammatory cytokine, osteopontin, on autoimmune demyelinating disease D Chabas, SE Baranzini, D Mitchell, CCA Bernard, SR Rittling, ... Science 294 (5547), 1731-1735, 2001 | 1054 | 2001 |
| Meta-analysis of genome scans and replication identify CD6, IRF8 and TNFRSF1A as new multiple sclerosis susceptibility loci PL De Jager, X Jia, J Wang, PIW De Bakker, L Ottoboni, NT Aggarwal, ... Nature genetics 41 (7), 776-782, 2009 | 943 | 2009 |
| Gut bacteria from multiple sclerosis patients modulate human T cells and exacerbate symptoms in mouse models E Cekanaviciute, BB Yoo, TF Runia, JW Debelius, S Singh, CA Nelson, ... Proceedings of the National Academy of Sciences 114 (40), 10713-10718, 2017 | 765 | 2017 |
| Gut microbiota from multiple sclerosis patients enables spontaneous autoimmune encephalomyelitis in mice K Berer, LA Gerdes, E Cekanaviciute, X Jia, L Xiao, Z Xia, C Liu, L Klotz, ... Proceedings of the National Academy of Sciences 114 (40), 10719-10724, 2017 | 734 | 2017 |
| Incidental MRI anomalies suggestive of multiple sclerosis: the radiologically isolated syndrome DT Okuda, EM Mowry, A Beheshtian, E Waubant, SE Baranzini, ... Neurology 72 (9), 800-805, 2009 | 642 | 2009 |
| Multiple sclerosis genomic map implicates peripheral immune cells and microglia in susceptibility International Multiple Sclerosis Genetics Consortium*†, ANZgene, ... Science 365 (6460), eaav7188, 2019 | 625 | 2019 |
| Dysregulation of the Wnt pathway inhibits timely myelination and remyelination in the mammalian CNS SPJ Fancy, SE Baranzini, C Zhao, DI Yuk, KA Irvine, S Kaing, N Sanai, ... Genes & development 23 (13), 1571-1585, 2009 | 619 | 2009 |
| Proteomic analysis of active multiple sclerosis lesions reveals therapeutic targets MH Han, SI Hwang, DB Roy, DH Lundgren, JV Price, SS Ousman, ... Nature 451 (7182), 1076-1081, 2008 | 569 | 2008 |
| Genome-wide association analysis of susceptibility and clinical phenotype in multiple sclerosis SE Baranzini, J Wang, RA Gibson, N Galwey, Y Naegelin, F Barkhof, ... Human molecular genetics 18 (4), 767-778, 2009 | 549 | 2009 |
| Genome, epigenome and RNA sequences of monozygotic twins discordant for multiple sclerosis SE Baranzini, J Mudge, JC Van Velkinburgh, P Khankhanian, ... Nature 464 (7293), 1351-1356, 2010 | 528 | 2010 |
| Pathway and network-based analysis of genome-wide association studies in multiple sclerosis SE Baranzini, NW Galwey, J Wang, P Khankhanian, R Lindberg, ... Human molecular genetics 18 (11), 2078-2090, 2009 | 467 | 2009 |
| The genetics of multiple sclerosis: SNPs to pathways to pathogenesis JR Oksenberg, SE Baranzini, S Sawcer, SL Hauser Nature Reviews Genetics 9 (7), 516-526, 2008 | 411 | 2008 |
| Heterogeneity at the HLA-DRB1 locus and risk for multiple sclerosis LF Barcellos, S Sawcer, PP Ramsay, SE Baranzini, G Thomson, F Briggs, ... Human molecular genetics 15 (18), 2813-2824, 2006 | 390 | 2006 |
| The genetics of multiple sclerosis: an up‐to‐date review PA Gourraud, HF Harbo, SL Hauser, SE Baranzini Immunological reviews 248 (1), 87-103, 2012 | 376 | 2012 |
| Mapping multiple sclerosis susceptibility to the HLA-DR locus in African Americans JR Oksenberg, LF Barcellos, BAC Cree, SE Baranzini, TL Bugawan, ... The American Journal of Human Genetics 74 (1), 160-167, 2004 | 376 | 2004 |
| B cell repertoire diversity and clonal expansion in multiple sclerosis brain lesions SE Baranzini, MC Jeong, C Butunoi, RS Murray, CCA Bernard, ... The Journal of Immunology 163 (9), 5133-5144, 1999 | 356 | 1999 |
| Class II HLA interactions modulate genetic risk for multiple sclerosis Nature genetics 47 (10), 1107-1113, 2015 | 347 | 2015 |
| Long‐term evolution of multiple sclerosis disability in the treatment era University of California, San Francisco MS‐EPIC Team:, BAC Cree, ... Annals of neurology 80 (4), 499-510, 2016 | 341 | 2016 |
Stephen L. HauserUCSFEmail verificata su ucsf.edu
